Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies

Scand J Rheumatol. 2010 May;39(3):247-53. doi: 10.3109/03009740903362511.

Abstract

Objective: Evaluation of the reactivity of autoantibodies of systemic lupus erythematosus (SLE) patients directed against malondialdehyde (MDA)-modified catalase, superoxide dismutase (SOD), and different Hep2 protein fractions (hydrophobic, hydrophilic, and nuclear).

Method: Thiol groups and MDA-protein adducts were first assessed among 65 SLE patients and 60 healthy controls. Then, the reactivities of SLE immunoglobulin (Ig)G autoantibodies towards MDA-modified and unmodified proteins were compared using a standard enzyme-linked immunosorbent assay (ELISA).

Results: An increase in the levels of MDA-modified proteins and a decrease in the concentration of thiol groups among SLE patients (p < 0.05) were observed. IgG circulating autoantibodies in the sera of SLE patients exhibited a significant enhanced reactivity (p < 0.05) against catalase and SOD-modified proteins. The same data were observed in the different protein fractions extracted from cultured cells (p < 0.05).

Conclusion: These data reinforce the role of oxidative stress and especially lipid peroxidation products in the progression of SLE disease.

MeSH terms

  • Analysis of Variance
  • Autoantibodies / blood
  • Autoantibodies / immunology*
  • Cells, Cultured
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Lupus Erythematosus, Systemic / blood
  • Lupus Erythematosus, Systemic / immunology*
  • Malondialdehyde / immunology*
  • Proteins / immunology*
  • Superoxide Dismutase / immunology*

Substances

  • Autoantibodies
  • Proteins
  • Malondialdehyde
  • Superoxide Dismutase